TY - JOUR
TI - Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes
AU - Zacharia, E.
AU - Antonopoulos, A.S.
AU - Oikonomou, E.
AU - Papageorgiou, N.
AU - Pallantza, Z.
AU - Miliou, A.
AU - Mystakidi, V.C.
AU - Simantiris, S.
AU - Kriebardis, A.
AU - Orologas, N.
AU - Valasiadi, E.
AU - Papaioannou, S.
AU - Galiatsatos, N.
AU - Antoniades, C.
AU - Tousoulis, D.
JO - Journal of Molecular and Cellular Cardiology
PY - 2020
VL - 138
TODO - null
SP - 110-114
PB - INSTAP Academic Press
SN - 0022-2828, 1095-8584
TODO - 10.1016/j.yjmcc.2019.11.153
TODO - C reactive protein;  phosphatidylserine, adult;  apoptosis;  Article;  blood vessel parameters;  brachial artery;  controlled study;  coronary artery disease;  endothelium cell;  erythrocyte;  female;  flow mediated dilatation;  human;  human cell;  major clinical study;  male;  non ST segment elevation myocardial infarction;  pathogenesis;  population research;  prevalence;  priority journal;  protein blood level;  risk factor;  ST segment elevation myocardial infarction;  stable coronary artery disease;  thrombocyte;  unstable angina pectoris;  acute coronary syndrome;  atherosclerotic plaque;  blood;  membrane microparticle;  metabolism;  middle aged;  pathology;  pathophysiology;  rupture;  vascular endothelium, Acute Coronary Syndrome;  Apoptosis;  Cell-Derived Microparticles;  Endothelium, Vascular;  Female;  Humans;  Male;  Middle Aged;  Plaque, Atherosclerotic;  Rupture
TODO - Objective: Circulating microvesicles (MV) are surrogate biomarkers of atherosclerosis. However, their role in acute coronary syndromes (ACS) has not been fully elucidated yet. We sought to examine the association of circulating apoptotic MVs with ACS pathophysiology. Approach and results: One hundred and fifty-three patients (n = 153) were included in the study; 49 patients with ST-elevation myocardial infarction (STEMI), 35 with non-STEMI (NSTEMI), 38 with unstable angina, 15 with stable coronary artery disease and 16 control individuals. Flow cytometry analysis was used to quantify circulating apoptotic/non-apoptotic (phospatidyloserine+/phospatidyloserine−) endothelial cell (EMV), red blood cell (RMV) and platelet (PMV) derived MV. Flow-mediated dilatation (FMD) of the brachial artery was assessed by ultrasound to estimate endothelial function. The inflammatory profile was assessed by serum C-reactive protein (hsCRP) levels. Apoptotic only (but not non-apoptotic) MV were increased in patients with ACS (EMV, P = 2.32 × 10−9; RMV, P = .0019; PMV, P = .01). Hierarchical clustering of the total population of ACS patients (n = 122) by circulating levels of phospatidyloserine+ EMV, RMV and PMV identified two discreet clusters of patients without any differences in traditional risk factors, but significant differences in brachial FMD (5.2% (2.5) vs. 4.1% (2.3), P < .05) that remained significant after adjustment for co-variates. The prevalence of STEMI, a surrogate for plaque rupture and vessel thrombotic occlusion, was significantly higher in the patient cluster with impaired endothelial function (60% vs 32%, P = .016, adjusted odds ratio for STEMI, 3.041, 95%CI, 1.160 to 7.968, p = .024). Conclusion: Our findings indicate that the circulating levels of apoptotic MV are increased in ACS patients and their plasma profiles associate with endothelial dysfunction and thrombotic complications in ACS patients. © 2019 Elsevier Ltd
ER -